A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

NCT07108283 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonsegmental Vitiligo

Interventions

DRUG: Zasocitinib
OTHER: Placebo

Sponsor

Takeda